Project description
A medical device for real-time analysis during tumour surgery
Surgical resection of tumours requires pre-operative planning, while the outcome is assessed through pathological examination after the operation. The rationale behind the EU-funded Olfactomics project is that real-time analysis of the operated tissue is necessary for optimal results. Researchers have developed a breakthrough medical device that assists surgeons in effectively resecting the tumour tissue, sparing the neighbouring normal tissue. The device does not compromise the workflow of the operation and can be employed for most soft-tissue surgeries, reducing the need for reoperation. Considering the number of tumour surgeries performed every year, there is a big market niche for the Olfactomics device.
Objective
Olfactomics is a Finnish university-based spinoff company developing a novel technology for surgical tissue assessment. The company has a breakthrough innovation on improving breast-conserving lumpectomies where a residual tumour continues to be an issue. Real-time tissue analysis allows the surgeon to remove a whole tumour in one operation and minimise the resection of healthy tissues. The patented technology (TRL 6) allows safer and more cost-effective cancer surgery and is scalable to most soft-tissue surgery. The unique device allows the surgeon to analyse the operated tissue in real-time during cancer surgery leading to optimal tissue removal.
There is a global economy-justified need for real-time analysis in surgery. The Olfactomics device is fully aligned with current clinical workflow and instrumentation. It can be efficiently implemented to 835 000 breast surgeries every year, and it is scalable to multiple other areas. The commercialisation is targeting to 250 M€ revenue by 2027.
The core team has the enthusiasm and knowledge needed for the commercialisation: team members are specialists in surgery, clinical medicine, medical technology, software, data analysis, financial sector and corporate law and have excellent connections in the international healthcare industry.
The aim of this feasibility study is to analyse the feasibility from different perspectives and detail the business plan for the global commercialisation of the technology. The first commercial product will be a research device launched 2019. The scale-up to medical device and applications on several surgical areas will follow.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine surgery surgical specialties
- medical and health sciences clinical medicine oncology breast cancer
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
33700 Tampere
Finland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.